Press Release 2018

Sabinsa Japan Corporation, a division of the Sami-Sabinsa Group, has signed a Memorandum of Understanding (MOU) with the Japan External Trade Organization (JETRO) to support Sabinsa’s expansion in Japan.

The MOU was signed during the 13th India-Japan Annual Summit, held between the Honorable Prime Minister of India Mr. Narendra Modi and the Honorable Prime Minister of Japan Mr. Shinzo Abe, on October 29, 2018 in Tokyo.

“As we continue our global expansion, we deeply appreciate the support of the Government of India and the trade development programs of the countries in which we do business, such as JETRO,” said Sabinsa founder Dr. Muhammed Majeed. “Although we have had an office in Japan for some time, the support of the Government of Japan as we continue our investment in that country will allow us to more quickly make our products to enhance human health available on a wider scale to the people of Japan.”

 

    VISIT US

  • Edifício Koerich Beiramar Office
    Avenida Mauro Ramos
    1970- Sala 705-Centro
    Florianópolis-SC
    Brasil CEP 88.020-302

  • +55 48 3206 3682
  • info@sabinsa.com.br

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.